Breaking News on Global Pharmaceutical Technology & Manufacturing

Hot Topics > Lifecycle management

Novo Nordisk and Roche' insulin pump collaboration gets EU thumbs up

26-Nov-2013 - Novo Nordisk has teamed up with Roche to launch a prefilled cartridge for insulin pump users and says the system offers advantages over injections.

Dispatches from AAPS

Non-oral FDCs are beneficial for patients and industry, say experts

13-Nov-2013 - Drug delivery experts say fixed dose combination (FDC) products for non-oral forms can benefit both the manufacturer and the patient.

News from CPhI

Second generation HPMC excipient can cut costs by 60%, says Dow

05-Nov-2013 - A new tableting excipient eliminates the need for wet granulation and saves up to 60% on overall manufacturing costs according to developer Dow.

Capsugel and Bend: 'Marriage made in heaven' as first tech transferred

31-Oct-2013 - The acquisition of Bend Research by Capsugel may be “a marriage made in heaven” for customers, the firms say, as the first drug delivery tech is transferred.

UPDATE - Dispatches from CPhI

Capsugel's purchase of Bend will strengthen partnership, says Dow

28-Oct-2013 - Dow says the acquisition of partner Bend Research is “good news” and will strengthen its developments in solving solubility and bioavailability issues in drug formulation.


Catalent launches softgel products at CPhI: one vegetarian, one anti-abuse

23-Oct-2013 - Catalent has announced two new softgel solutions as it adds greater versatility to its Advanced Technologies Business Unit.

Almac and Novozymes team to offer pharmacokinetic improvements

22-Oct-2013 - Linking peptide and small molecule drugs to albumin will improve pharmacokinetics, says Almac as it partners its manufacturing capabilities with Novozymes’ half-life extension platform.

Cirrus studies formulation effects on MDI performance for US FDA

17-Oct-2013 - Cirrus Pharmaceuticals has received a grant to investigate the effect of excipient concentration and API molecule size on metered dose inhaler (MDI) formulations.

Giant Leap for Mannkind: Positive data from Ph III Afrezza trial

19-Aug-2013 - Mannkind says it is looking for partners to market its inhaled insulin drug Afrezza following positive data results in Phase III clinical trials.

Benefit Analysis Reqs Are More Work but Revised PSURs Are Better says EFPIA

09-Apr-2013 - Recent changes to EU drug risk-benefit reporting rules mean more work for multinational Pharmas but are still an improvement on ‘old-style’ PSURs says EFPIA.

EC says Drugmakers Have Time to Mark Risky Drugs with Black Triangle

11-Mar-2013 - The European Commission (EC) says timelines for new laws requiring that risky drugs are marked for extra safety monitoring take industry practicalities into account.

DSM says generics-focused partnering will drive pharma growth

20-Feb-2013 - Royal DSM expects its pharma unit to perform better in 2013 driven by a generics and end-of-lifecycle drug-focused partnership strategy. 

AMRI Deal a Catalyst for Pharma Growth says Codexis

14-Feb-2013 - AMRI has teamed up with biocatalysis firm Codexis to develop cheaper, faster and greener ways of manufacturing APIs.


Teva to Sell Californian Plant as Part of Cost-Cutting Initiative

11-Feb-2013 - Teva says the offloading of its Californian manufacturing facility is part of cost-cutting plans designed to save $2bn (€1.5bn). in the next few years.

Pfizer wants manufacturing 'efficiencies' in 2013

30-Jan-2013 - Pfizer's CEO has raised the possibility of more cost cutting in manufacturing operations in 2013 to offset the impact of patent loss for key products.

Lilly’s in-house trend continues with $140m insulin investment

05-Nov-2012 - Eli Lilly plans to boost its in-house insulin production capabilities will a $140m investment for its Indianapolis site.

Disptaches from AAPS

Eliminate scale up by using R&D equipment for commercial production: GSK

18-Oct-2012 - Using the same equipment from R&D to scale up will cut costs, time and improve efficiency, according to GSK.

Regulatory staff wages going up despite cost cutting pharma biz, says RAPS

21-Aug-2012 - Regulatory professionals’ pay packets are going up despite a general industry preference for cost cutting, according to a new report by RAPS.

India launches 'similar biologics' guidelines at BIO2012

20-Jun-2012 - New 'similar biologics' guidelines will curb the rising cost of innovation, attract overseas investment and ensure patients have access to drugs according to the Indian Government team which launched them...

Biogen preps for shrinking MS injectables market

14-Jun-2012 - Biogen Idec expects the market for injectable MS drugs to shrink as patients choose more convenient delivery forms.

Lilly looks to drug delivery to win share in insulin market

13-Jun-2012 - Eli Lilly will use its drug delivery device capabilities to boost the competitiveness of its developmental basal insulins, the firm’s SVP said.

Chocolate drug delivery has NIH interest, Lycotec CEO says

12-Jun-2012 - The CEO of Lycotec says its chocolate formulation of a liver-targeted oral compound has attracted interest from the NIH and FDA.

More HIV drugmakers to stabilise the South African supply chain, says Aspen

11-Jun-2012 - The upcoming tender for antiretroviral meds (ARVs) in South Africa will be opened up to more companies in a bid to tackle shortages, an insider told us.

Round up of drug delivery news

07-Jun-2012 - presents a roundup of drug delivery news, including a FDA set back at Amylin and expansion at Particle Sciences.

Aptar to enter injectable device components with €165m buy

04-Jun-2012 - AptarGroup is buying Stelmi for €165m ($205m) to expand into primary packaging components for injectable delivery devices.

Key Industry Events


Access all events listing

Our events, Shows & Conferences...